Is low selenium status a risk factor for lung cancer?

American Journal of Epidemiology

Volumn 148, Issue 10, 1998, Pages 975-982

  Knekt, Paul ^a   Marniemi, Jukka ^b   Teppo, Lyly ^c   Heliövaara, Markku ^a   Aromaa, Arpo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

Author keywords

Follow up studies; Lung; Neoplasms; Selenium; Serum

Indexed keywords

COPPER; SELENIUM;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; COPPER BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FINLAND; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SELENIUM DEFICIENCY; SMOKING;

EID: 0032533596     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009574     Document Type: Article

References (41)

1. van Poppel G. Carotenoids and cancer: an update with emphasis on human intervention studies. Eur J Cancer 1993;29A: 1335-44.
2. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
3. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
4. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
5. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
6. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-63.
7. Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990;82:864-8.
8. van den Brandt PA, Goldbohm RA, van't Veer P, et al. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 1993;53:4860-5.
9. Menkes MS, Comstock GW, Vuilleumier JP, et al. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986;315:1250-4.
10. Nomura A, Heilbrun LK, Morris JE, et al. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst 1987;79:103-8.
11. Kabuto M, Imai H, Yonezawa C, et al. Prediagnostic serum selenium and zinc levels and subsquent risk of lung cancer and stomach cancer in Japan. Cancer Epidemiol Biomarkers Prev 1994;3:465-9.
12. Garland M, Morris JS, Stampfer MJ, et al. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 1995;87:497-505.
13. Blot WJ, Li JY, Taylor PR, et al. Lung cancer and vitamin supplementation. (Letter). N Engl J Med 1994;331:614.
14. Reunanen A, Aromaa A, Pyörälä K, et al. The Social Insurance Institution's Coronary Heart Disease Study. Baseline data and 5-year mortality experience. Acta Scand Med 1983; (suppl 673).
15. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
16. Saeed K, Thomassen Y, Langmyhr FJ. Direct electrothermal atomic absorption spectrometric determination of selenium in serum. Anal Chim Acta 1979;110:285-9.
17. Alfthan G, Kumpulainen J. Determination of selenium in small volumes of blood plasma and serum by electrothermal atomic absorption spectrometry. Anal Chim Acta 1982;140: 221-7.
18. Milne DB, Botnen J. Retinol, alpha-tocopherol, lycopene and alpha-and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986;32: 874-6.
19. Meret S, Henkin RI. Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid. Clin Chem 1971;17:369-73.
20. Craft NE, Brown ED, Smith JC Jr. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. Clin Chem 1988;34: 44-8.
21. Ocke MC, Schrijver J, Obermann-de Boer GL, et al. Stability of blood (pro)vitamins curing four years of storage at - 20°C: consequences for epidemiologic research. J Clin Epidemiol 1995;48:1077-85.
22. Aromaa A. Kohonnut verenpaine ja sen kansanterveydellinen merkitys Suomessa. (English summary: Epidemiology and public health impact of high blood pressure in Finland.) Helsinki: Kansaneläkelaitoksen julkaisuja AL:17, 1981.
23. Garland M, Morris JS, Rosner BA, et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 1993;2:493-7.
24. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. (IARC publications no. 32). Lyon: IARC, 1980.
25. Winer BJ. Statistical principles in experimental design. 2nd ed. Tokyo: McGraw-Hill and Kogakusha, 1971.
26. Aro A, Alfthan G, Varo P. Effects of supplementation of fertilizers on human selenium status in Finland. Analyst 1995; 120:841-3.
27. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/ mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85:1483-92.
28. Knekt P. Vitamin E and cancer prevention. In: Frei B, ed. Natural antioxidants in human health and disease. New York: Academic Press, 1994:199-238.
29. Nomura AMY, Stemmermann GN, Heilbrun LK, et al. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res 1985;45:2369-72.
30. Wald NJ, Thompson SG, Densem JW, et al. Serum beta-carotene and subsequent risk of cancer: results from the BUPA Study. Br J Cancer 1988;57:428-33.
31. Knekt P, Aromaa A, Maatela J, et al. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol 1988;127:28-41.
32. Connett JE, Kuller LH, Kjelsberg MO, et al. Relationship between carotenoids and cancer. The Multiple Risk Factor Intervention Trial (MRFIT) Study. Cancer 1989;64:126-34.
33. Knekt P, Järvinen R, Seppänen R, et al. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol 1991;134:471-9.
34. Orentreich N, Matias JR, Vogelman JH, et al. The predictive value of serum beta-carotene for subsequent development of lung cancer. (Letter). Nutr Cancer 1991;16:167-9.
35. Stähelin HB, Gey KF, Eichholzer M, et al. Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel Study. Am J Epidemiol 1991;133:766-75.
36. Hoekstra WG. Biochemical function of selenium and its relation to vitamin E. Fed Proc 1975;34:2083-9.
37. Knekt P. Vitamin E and smoking and the risk of lung cancer. Ann NY Acad Sci 1993;686:280-8.
38. Solomons NW. Biochemical, metabolic, and clinical role of copper in human nutrition. J Am Coll Nutr 1985;4:83-105.
39. Knekt P, Aromaa A, Maatela J, et al. Serum ceruloplasmin and the risk of cancer in Finland. Br J Cancer 1992;65:292-6.
40. Oyama T, Matsuno K, Kawamoto T, et al. Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer. Biol Trace Elem Res 1994;42:115-27.
41. Fan C, Stendahl U, Stjernberg N, et al. Association between orosomucoid types and cancer. Oncology 1995;52:498-500.